Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: A 5-year prospective study

Journal of Acquired Immune Deficiency Syndromes

Volumn 24, Issue 4, 2000, Pages 378-385

  Hung, Chien Ching ^a,b   Chen, Mao Yuan ^a   Hsieh, Szu Min ^a   Sheng, Wang Hwei ^a,c   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

AIDS; Highly active antiretroviral therapy (HAART); HIV infection; Morbidity; Mortality; Opportunistic infection; Taiwan

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CANDIDIASIS; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; DEVELOPING COUNTRY; FEMALE; HERPES SIMPLEX; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; TAIWAN; TUBERCULOSIS;

EID: 0034253001     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200008010-00013     Document Type: Article

References (34)

1. HIV and AIDS in the Asia-Pacific region: An epidemiological overview
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
3. Impact of protease in-hibitors on AIDS defining events and hospitalizations in 10 French AIDS reference centers
4. Changing patterns of mortality across Europe in patients infected with HIV
5. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
6. Decline in deaths from AIDS due to new antiretrovirals
7. The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection
8. The incidence and spec-trum of AIDS-defining illnesses in patients treated with antiretro-viral therapy
9. Factors affecting survival in patients with the acquired immunodeficiency syndrome
10. The current state of human immunodeficiency virus infection and antiretroviral care in Taiwan
11. The role of tissue studies in facilitating early initiation of antimy-cobacterial treatment in AIDS patients with disseminated mycobacterial disease
12. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with the human immunodeficiency virus: A summary
13. 1993 Revised classification system for HIV infection and expanded case definition for AIDS among adolescents and adults
14. Invasive infection caused by Penicillium marneffei: An emerging pathogen in Taiwan
15. Invasive amebiasis: An emerging parasitic disease of patients infected with human immunodeficiency virus in an endemic area of amebic infection
16. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons
17. Distribution of CD4+ lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus related illnesses
18. Natural history of opportunistic disease in an HIV-infected urban clinical cohort
19. The incidence of AIDS defining illnesses in 4883 patients with human immunodeficiency virus infection
20. Clinical manifestations of AIDS in the era of Pneumocystis carinii prophylaxis
21. Bacterial pneumonia in persons infected with the human immunodeficiency virus
22. Bacteremia and fungemia in patients with advanced human immunodeficiency virus (HIV) infection in Taiwan
23. Clinical features of tuberculosis associated with HIV infection in Taiwan
24. Clinical features and outcome in disseminated mycobacterial diseases in AIDS patients in Taiwan
25. Clinical spectrum of HIV/AIDS in the Asia-Pacific region
26. Screening of human immunodeficiency virus infection in pulmonary tuberculosis patients in Taiwan
27. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection
28. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis
29. Drug resistance patterns of tuberculosis in Taiwan
30. Randomized trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection
31. Physician's experience with the acquired immunodeficiency syndrome as a factor in patients' survival
32. Clinical experience and choice of drug therapy for human immunodeficiency virus disease